CKS is no longer commissioned by the National Institute for Health and Clinical Excellence (NICE). NICE remains committed to providing a replacement service for CKS and is currently reviewing its options. In the meantime, although CKS content is now not being maintained, it still remains relevant and will continue to be made available. CKS content was generated under a programme of topic creation and update. To check if the topic you are viewing is current or out of date, please refer to the topic publication details by clicking on the 'How up-to-date is this topic?' link in the left hand menu on individual topic pages.
Contraception - emergency - Management
What issues need to be considered when prescribing oral ulipristal acetate emergency contraception?
This level contains the following sections:
- Available products
- Advice
- Contraindications and cautions
- Suitability during breast feeding
- Safety during pregnancy
- Adverse effects
- Drug interactions
- Women on a liver enzyme-inducing drug
- Continuing oral contraception
- Initiation of hormonal contraception
© NHS Institute for Innovation and Improvement